Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyper Eosinophilic Syndrome”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Large-scale testing (Phase 3)Study completedNCT02135692
What this trial is testing

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Who this might be right for
Asthma
GlaxoSmithKline 339
Testing effectiveness (Phase 2)Study completedNCT04674137
What this trial is testing

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

Who this might be right for
Bronchial AsthmaEosinophilic Asthma
Chemlmmune Therapeutics LLC 70
Not applicableNo Longer AvailableNCT04498871
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With HES

Who this might be right for
Hypereosinophilic Syndrome (HES)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT02852928
What this trial is testing

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Who this might be right for
Lung Diseases, InterstitialPulmonary Alveolar ProteinosisPulmonary Eosinophilia+3 more
Matthias Griese 1,000
Not applicableUnknownNCT05398133
What this trial is testing

Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma

Who this might be right for
COPD AsthmaEosinophilic Asthma
Medical University of Warsaw 36
Testing effectiveness (Phase 2)Study completedNCT02560610
What this trial is testing

Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

Who this might be right for
Severe Eosinophilic Asthma
Chiesi Farmaceutici S.p.A. 40
Not applicableActive Not RecruitingNCT06069310
What this trial is testing

Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma

Who this might be right for
Chronic Rhinosinusitis With Nasal PolypsSevere Eosinophilic AsthmaChronic Rhinosinusitis Without Nasal Polyps
National and Kapodistrian University of Athens 40
Not applicableUnknownNCT05787678
What this trial is testing

Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion

Who this might be right for
Asthma; Eosinophilic
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Not applicableStudy completedNCT04680611
What this trial is testing

Severe Asthma, MepolizumaB and Affect: SAMBA Study

Who this might be right for
Severe Eosinophilic AsthmaPsychological DistressAnxiety+14 more
University Hospital Southampton NHS Foundation Trust 120
Not applicableStudy completedNCT04187976
What this trial is testing

Eosinophils Endotypes in Chronic Airway Inflammatory Diseases

Who this might be right for
Eosinophilic AsthmaChronic SinusitisEosinophilic Rhinitis
University Hospital, Lille 70
Testing effectiveness (Phase 2)Study completedNCT03683576
What this trial is testing

GB001 in Adult Subjects With Moderate to Severe Asthma

Who this might be right for
Asthma
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. 481
Large-scale testing (Phase 3)Looking for participantsNCT06750289
What this trial is testing

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

Who this might be right for
Eosinophilic Asthma
AstraZeneca 400
Not applicableUnknownNCT04512521
What this trial is testing

Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Hannover Medical School 40
Testing effectiveness (Phase 2)Looking for participantsNCT06477653
What this trial is testing

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableEnded earlyNCT06302959
What this trial is testing

Clock Proteins as Prognostic Markers

Who this might be right for
Severe Eosinophilic Asthma
Medical University of Graz 50
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Post-approval studies (Phase 4)Study completedNCT04276233
What this trial is testing

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Who this might be right for
Asthma
GlaxoSmithKline 100
Post-approval studies (Phase 4)Study completedNCT04159519
What this trial is testing

Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Who this might be right for
AsthmaSevere Eosinophilic Asthma
AstraZeneca 170
Large-scale testing (Phase 3)Study completedNCT02836496
What this trial is testing

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Who this might be right for
Hypereosinophilic Syndrome
GlaxoSmithKline 108
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Next Page